Sign in
A randomized, double-blind, placebo-controlled study of latrepirdine in patients with mild to moderate Huntington disease
Journal article   Open access  Peer reviewed

A randomized, double-blind, placebo-controlled study of latrepirdine in patients with mild to moderate Huntington disease

K Kieburtz, G B Landwehrmeyer, M Cudkowicz, E R Dorsey, A Feigin, V Hunt, E Kayson, M McDermott, S Noonberg, W Seitz, …
JAMA neurology, Vol.70(1), pp.25-33
2013
PMID: 23108692

Abstract

Neurologi Farmakologi och toxikologi Klinisk medicin Medicin och hälsovetenskap Medicinska och farmaceutiska grundvetenskaper
url
https://doi.org/10.1001/2013.jamaneurol.382View
Published (Version of record) Open

Metrics

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types
Domestic collaboration
International collaboration
Citation topics
1 Clinical & Life Sciences
1.52 Neurodegenerative Diseases
1.52.951 Huntington's Disease
Web Of Science research areas
Clinical Neurology
ESI research areas
Neuroscience & Behavior

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

Source: InCites

Details